Literature DB >> 25055890

Laparoscopic left hepatectomy with tumor thrombectomy in patients with hepatocellular carcinoma concomitant with advanced portal vein tumor thrombus.

Shin Nakahira1, Yutaka Takeda, Yoshiteru Katsura, Takeshi Kato, Nobutaka Hatanaka, Shigeyuki Tamura.   

Abstract

BACKGROUND: Although laparoscopic hepato-biliary-pancreatic surgery has been widely adopted, use of laparoscopic resection for hepatocellular carcinoma (HCC) with advanced portal vein tumor thrombus (PVTT) is uncommon because of the complications involved.
METHODS: From June 2010 through November 2013, 200 laparoscopic hepatectomies were performed. We report the short-term outcome of laparoscopic hepatectomy for HCC with advanced PVTT in 3 patients. Video presentation is a demonstration of the operative procedures employed in Case 3. In this case, the left hepatic artery and left hepatic duct were divided before tumor thrombectomy, and the bifurcation of the portal vein was clearly visible.
RESULTS: Three female patients with HCC concomitant with PVTT in the portal trunk or the opposite branch underwent laparoscopic left hepatectomy with tumor thrombectomy using a laparoscopy-assisted technique (1 patient) or pure laparoscopic technique (2 patients). The median operative time was 592 min (range, 555-891 min), and median estimated blood loss was 1182 ml (range, minimal amount-4800 ml). The median length of hospital stay was 19 days (range, 9-22 days), and there was no postoperative mortality. In Case 1, recurrent tumors developed in the residual lobe after curative resection, and the patient died 10 months after the surgery despite treatment with sorafenib and transcatheter arterial chemoembolization. In Case 2, the patient survived for 10 months after curative resection without tumor recurrence. In Case 3, the patient was treated with sorafenib 1 month after palliative resection; she survived for 4 postoperative months, during which decreased tumor marker levels were observed.
CONCLUSIONS: Laparoscopic hepatectomy for HCC with advanced PVTT is a safe and feasible procedure in selected patients, when performed by surgeons with expertise in hepatic surgery and minimally invasive techniques. Although these patients cannot be cured by surgery alone, early adjuvant therapy followed by laparoscopic surgery might contribute to a good outcome.

Entities:  

Mesh:

Year:  2014        PMID: 25055890     DOI: 10.1007/s00464-014-3729-x

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  4 in total

Review 1.  Laparoscopic and robotic approach for hepatocellular carcinoma-state of the art.

Authors:  Giovanni Battista Levi Sandri; Edoardo de Werra; Gianluca Mascianà; Marco Colasanti; Roberto Santoro; Vito D'Andrea; Giuseppe Maria Ettorre
Journal:  Hepatobiliary Surg Nutr       Date:  2016-12       Impact factor: 7.293

Review 2.  Laparoscopic Left Hepatectomy for Ruptured Hepatocellular Carcinoma Controlled After Transcatheter Arterial Embolization: Case Report and Review of the Literature.

Authors:  Shohei Yoshiya; Kentaro Iwaki; Akihiro Sakai; Shunsuke Fujita; Takahide Kawasaki; Fumitaka Yoshizumi; Shoji Hiroshige; Masahiro Okamoto; Kengo Fukuzawa; Akira Motohiro; Yoshihiko Maehara
Journal:  In Vivo       Date:  2018 May-Jun       Impact factor: 2.155

3.  The Asia Pacific Consensus Statement on Laparoscopic Liver Resection for Hepatocellular Carcinoma: A Report from the 7th Asia-Pacific Primary Liver Cancer Expert Meeting Held in Hong Kong.

Authors:  Tan To Cheung; Ho-Seong Han; Wong Hoi She; Kuo-Hsin Chen; Pierce K H Chow; Boon Koon Yoong; Kit Fai Lee; Shoji Kubo; Chung Ngai Tang; Go Wakabayashi
Journal:  Liver Cancer       Date:  2017-12-09       Impact factor: 11.740

4.  Prospective, single-center cohort study analyzing the efficacy of complete laparoscopic resection on recurrent hepatocellular carcinoma.

Authors:  Jie Zhang; Zhong-Guo Zhou; Zhong-Xi Huang; Ke-Li Yang; Jian-Cong Chen; Jin-Bin Chen; Li Xu; Min-Shan Chen; Yao-Jun Zhang
Journal:  Chin J Cancer       Date:  2016-03-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.